193 related articles for article (PubMed ID: 15813424)
1. Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab) treatment.
Efde MN; Houtman PM; Spoorenberg JP; Jansen TL
Neth J Med; 2005 Mar; 63(3):112-4. PubMed ID: 15813424
[TBL] [Abstract][Full Text] [Related]
2. Side effects of anticytokine strategies.
van der Meer JW; Popa C; Netea MG
Neth J Med; 2005 Mar; 63(3):78-80. PubMed ID: 15813418
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy.
van Ingen J; Boeree M; Janssen M; Ullmann E; de Lange W; de Haas P; Dekhuijzen R; van Soolingen D
Nat Clin Pract Rheumatol; 2007 Jul; 3(7):414-9. PubMed ID: 17599076
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary tuberculosis associated to adalimumab: a study of 3 cases].
Blanco Pérez JJ; Aranda Torres A; Pego Reigosa JM; Núñez Delgado M; Temes Montes E; Guerra Vales JL
Arch Bronconeumol; 2010 Apr; 46(4):203-5. PubMed ID: 19896259
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.
Sichletidis L; Settas L; Spyratos D; Chloros D; Patakas D
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1127-32. PubMed ID: 17044206
[TBL] [Abstract][Full Text] [Related]
6. The association of secondary tonsillar and laryngeal tuberculosis: a case report and literature review.
Sutbeyaz Y; Ucuncu H; Murat Karasen R; Gundogdu C
Auris Nasus Larynx; 2000 Oct; 27(4):371-4. PubMed ID: 10996500
[TBL] [Abstract][Full Text] [Related]
7. [Case of rheumatoid arthritis presenting with pulmonary tuberculosis].
Katoh K; Taniguchi H; Okouchi A; Kudo M; Kawai T
Nihon Kokyuki Gakkai Zasshi; 2004 Aug; 42(8):782-6. PubMed ID: 15455955
[TBL] [Abstract][Full Text] [Related]
8. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis.
Stokes MB; Foster K; Markowitz GS; Ebrahimi F; Hines W; Kaufman D; Moore B; Wolde D; D'Agati VD
Nephrol Dial Transplant; 2005 Jul; 20(7):1400-6. PubMed ID: 15840673
[TBL] [Abstract][Full Text] [Related]
9. Tuberculous peritonitis after treatment with adalimumab.
Antolín J; Azahara M; Hernández C; Blanco M; Mao L; Cigüenza R
Scand J Infect Dis; 2008; 40(8):677-8. PubMed ID: 18979608
[TBL] [Abstract][Full Text] [Related]
10. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial.
Burmester GR; Mariette X; Montecucco C; Monteagudo-Sáez I; Malaise M; Tzioufas AG; Bijlsma JW; Unnebrink K; Kary S; Kupper H
Ann Rheum Dis; 2007 Jun; 66(6):732-9. PubMed ID: 17329305
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis.
Burr ML; Malaviya AP; Gaston JH; Carmichael AJ; Ostör AJ
Rheumatology (Oxford); 2008 May; 47(5):738-9. PubMed ID: 18375402
[No Abstract] [Full Text] [Related]
12. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
13. Tonsillar tuberculosis associated with pulmonary and laryngeal foci.
Yamamoto K; Iwata F; Nakamura A; Iwashima Y; Miyaki T; Yamada H; Kurachi M; Sato Y; Tsukada K; Takeuchi T; Joh T; Yokoyama Y; Itoh M
Intern Med; 2002 Aug; 41(8):664-6. PubMed ID: 12211539
[TBL] [Abstract][Full Text] [Related]
14. Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay.
Chen DY; Shen GH; Chen YM; Chen HH; Hsieh CW; Lan JL
Ann Rheum Dis; 2012 Feb; 71(2):231-7. PubMed ID: 22021896
[TBL] [Abstract][Full Text] [Related]
15. [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases].
Benucci M; Nenci G; Cappelletti C; Manfredi M
Recenti Prog Med; 2008; 99(7-8):363-6. PubMed ID: 18751615
[TBL] [Abstract][Full Text] [Related]
16. Nephrotic syndrome as a complication of anti-TNFalpha in a patient with rheumatoid arthritis.
den Broeder AA; Assmann KJ; van Riel PL; Wetzels JF
Neth J Med; 2003 Apr; 61(4):137-41. PubMed ID: 12852723
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
[TBL] [Abstract][Full Text] [Related]
19. Disseminated tuberculosis secondary to adalimumab.
Pednekar M; Chandra AB; Chandra PA
Am J Ther; 2012 Jul; 19(4):e139-40. PubMed ID: 20838203
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series.
Toussirot E; Berthelot JM; Pertuiset E; Bouvard B; Gaudin P; Wendling D; le Noach J; Lohse A; Lecuyer E; Cri L
J Rheumatol; 2009 Nov; 36(11):2421-7. PubMed ID: 19797509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]